Peptide

Leuprolide

FDA-approved product existsGH axis & hormones
Not yet scored

BioHarmony verdict

Awaiting review

No BioHarmony report yet. It is queued for review; until then, rely on the status and sources below.

What is Leuprolide?

Multiple FDA-approved leuprolide formulations exist. Their indications, release periods, doses, and preparation requirements are product-specific and not interchangeable.

Dosing as published

Approved labelLeuprolide acetate daily-injection kit prescribing information for advanced prostate cancer
PopulationAdults covered by the approved daily leuprolide indication
Dose1 mg (0.2 mL)
RouteSubcutaneous injection with periodic site rotation
FrequencyOnce daily
DurationLong-term use within the approved indication
PreparationReady-to-use solution in a 2.8 mL multiple-dose vial; no reconstitution. Inspect for discoloration or particles before use.
Source: Dosage and Administration; How Supplied

More reported protocols

Members

Members can compare additional reported doses, schedules, and preparation notes.

Trust & sourcing

US approvalFDA-approved product exists
CompoundingFDA-approved products exist; compounded copies are not FDA approved
Last checked2026-07-13
Next review2026-10-11

Primary sources

Free guide

The Ultimate Peptides Guide

Spot stronger candidates, weak evidence, and seller red flags before you buy.

Free. Includes evidence and regulatory updates. Unsubscribe anytime.